These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 26207435)

  • 1. Characterization of midazolam metabolism in locusts: the role of a CYP3A4-like enzyme in the formation of 1'-OH and 4-OH midazolam.
    Olsen LR; Gabel-Jensen C; Wubshet SG; Kongstad KT; Janfelt C; Badolo L; Hansen SH
    Xenobiotica; 2016; 46(2):99-107. PubMed ID: 26207435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a functional homolog of the mammalian CYP3A4 in locusts.
    Olsen LR; Gabel-Jensen C; Nielsen PA; Hansen SH; Badolo L
    Drug Metab Dispos; 2014 Jul; 42(7):1153-62. PubMed ID: 24778367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone.
    Mäenpää J; Hall SD; Ring BJ; Strom SC; Wrighton SA
    Pharmacogenetics; 1998 Apr; 8(2):137-55. PubMed ID: 10022752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of ketoconazole on praziquantel pharmacokinetics and the role of CYP3A4 in the formation of X-OH-praziquantel and not 4-OH-praziquantel.
    Nleya L; Thelingwani R; Li XQ; Cavallin E; Isin E; Nhachi C; Masimirembwa C
    Eur J Clin Pharmacol; 2019 Aug; 75(8):1077-1087. PubMed ID: 31089768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
    Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ
    J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interaction of intravenous fentanyl with ketoconazole.
    Ziesenitz VC; König SK; Mahlke NS; Skopp G; Haefeli WE; Mikus G
    J Clin Pharmacol; 2015 Jun; 55(6):708-17. PubMed ID: 25651378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450-dependent metabolism of midazolam in hepatic microsomes from chickens, turkeys, pheasant and bobwhite quail.
    Cortright KA; Craigmill AL
    J Vet Pharmacol Ther; 2006 Dec; 29(6):469-76. PubMed ID: 17083450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of continuous ingestion of Schisandrin A on CYP3A in the rat.
    Li WL; Xin HW; Su MW
    Basic Clin Pharmacol Toxicol; 2012 Feb; 110(2):187-92. PubMed ID: 21895978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-drug interactions and metabolism in cytochrome P450 2C knockout mice: application to troleandomycin and midazolam.
    Grimsley A; Gallagher R; Hutchison M; Pickup K; Wilson ID; Samuelsson K
    Biochem Pharmacol; 2013 Aug; 86(4):529-38. PubMed ID: 23732297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential metabolism of midazolam in mouse liver and intestine microsomes: a comparison of cytochrome P450 activity and expression.
    Perloff MD; Von Moltke LL; Greenblatt DJ
    Xenobiotica; 2003 Apr; 33(4):365-77. PubMed ID: 12745872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of enzyme kinetics of warfarin analyzed by LC-MS/MS QTrap and differential mobility spectrometry.
    Shaik AN; Grater R; Lulla M; Williams DA; Gan LL; Bohnert T; LeDuc BW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1008():164-173. PubMed ID: 26655108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of age on in vitro midazolam biotransformation in male CD-1 mouse liver microsomes.
    Warrington JS; Poku JW; von Moltke LL; Shader RI; Harmatz JS; Greenblatt DJ
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1024-31. PubMed ID: 10688619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential metabolism of AMG 487, a novel CXCR3 antagonist, results in formation of quinone reactive metabolites that covalently modify CYP3A4 Cys239 and cause time-dependent inhibition of the enzyme.
    Henne KR; Tran TB; VandenBrink BM; Rock DA; Aidasani DK; Subramanian R; Mason AK; Stresser DM; Teffera Y; Wong SG; Johnson MG; Chen X; Tonn GR; Wong BK
    Drug Metab Dispos; 2012 Jul; 40(7):1429-40. PubMed ID: 22517972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereospecific metabolism of itraconazole by CYP3A4: dioxolane ring scission of azole antifungals.
    Peng CC; Shi W; Lutz JD; Kunze KL; Liu JO; Nelson WL; Isoherranen N
    Drug Metab Dispos; 2012 Mar; 40(3):426-35. PubMed ID: 22106171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model.
    Cummins CL; Salphati L; Reid MJ; Benet LZ
    J Pharmacol Exp Ther; 2003 Apr; 305(1):306-14. PubMed ID: 12649383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.
    Tsunoda SM; Velez RL; von Moltke LL; Greenblatt DJ
    Clin Pharmacol Ther; 1999 Nov; 66(5):461-71. PubMed ID: 10579473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug interaction of efavirenz and midazolam: efavirenz activates the CYP3A-mediated midazolam 1'-hydroxylation in vitro.
    Keubler A; Weiss J; Haefeli WE; Mikus G; Burhenne J
    Drug Metab Dispos; 2012 Jun; 40(6):1178-82. PubMed ID: 22415932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation.
    Backman JT; Mäenpää J; Belle DJ; Wrighton SA; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Apr; 67(4):382-90. PubMed ID: 10801247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of terfenadine and its metabolites in locusts studied by desorption electrospray ionization mass spectrometry imaging.
    Olsen LR; Hansen SH; Janfelt C
    Anal Bioanal Chem; 2015 Mar; 407(8):2149-58. PubMed ID: 25404166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drug.
    Tham LS; Lee HS; Wang L; Yong WP; Fan L; Ong AB; Sukri N; Soo R; Lee SC; Goh BC
    Ther Drug Monit; 2006 Apr; 28(2):255-61. PubMed ID: 16628140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.